With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.
Our International Life Sciences & Healthcare group works with over 50% of the world’s largest pharmaceutical, biotechnology and medical devices companies. We have the largest patent litigation group in Europe and are recognised by major global directories as a top tier life sciences firm.
Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment. Our multidisciplinary team of 240 specialist life sciences and healthcare lawyers worldwide can advise you on every aspect of the business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property.
We can advise you on:
If you would like to know more about how we can help your business, please contact Heads of Group: Marc Martens in Brussels and Mark Hilton in London.
Legal 500, 2020
Chambers UK, 2020
Chambers Asia-Pacific, 2020
Chambers Europe, 2019
The outbreak of Novel Coronavirus (COVID-19) has sparked fears of a worldwide pandemic. Based on the World Health Organization’s declaration that this is a public health emergency of international concern, the Finnish ...
The draft amended Patent Law contains several other new provisions in addition to the Patent Linkage and the SPP provisions, such as the draft Article 24 which proposes a six month grace period of novelty for an ...
From 1 July 2020, advertisers of medicines will no longer be required to seek pre-approval from the Therapeutic Goods Administration (TGA) for advertisements of therapeutic goods in mainstream media (including ...
We are delighted to announce that our Life Sciences team has won two awards at the 8th annual LMG European Life Sciences Awards 2020.
International law firm Bird & Bird today expands its Intellectual Property practice with the appointment of patent litigation specialist José Miguel Lissén Arbeloa as a partner in Madrid.
Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB, subsidiary of Novavax Inc, US ...
There are no forthcoming events for this area. Please click on the button below to view past events.
Our latest BioTalk post: Australian Export Legislation Amendments Smooth the Way for Cannabis Export… https://t.co/R4JfEOsWrv
RT @twobirdsIP: Chris de Mauny and Neil Jenkins consider the judgment handed down by the UK #supremecourt today, upholding the appeal of Ky…
Our latest BioTalk article: Transfer of value in France: the long-awaited “anti-gift” decree has finally been publi… https://t.co/hoBtpNUBq6